2010
DOI: 10.4161/chan.4.4.12905
|View full text |Cite
|
Sign up to set email alerts
|

TRPV4-mediated channelopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
56
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 64 publications
(57 citation statements)
references
References 79 publications
1
56
0
Order By: Relevance
“…Mutations causing neuropathies probably have a lower penetrance than mutations causing skeletal dysplasias; this may explain why skeletal diseases often show no neurologic symptoms. Because of the high expression of TRPV4 in the inner ear and the urothelium, it is not surprising that some patients have also hearing problems and/or bladder symptoms such as overactive bladder and incontinence (reviewed in Verma et al, 2010).…”
Section: Trp Channels As Drug Targetsmentioning
confidence: 99%
“…Mutations causing neuropathies probably have a lower penetrance than mutations causing skeletal dysplasias; this may explain why skeletal diseases often show no neurologic symptoms. Because of the high expression of TRPV4 in the inner ear and the urothelium, it is not surprising that some patients have also hearing problems and/or bladder symptoms such as overactive bladder and incontinence (reviewed in Verma et al, 2010).…”
Section: Trp Channels As Drug Targetsmentioning
confidence: 99%
“…This is in agreement with the many mutations in TRPV4 which have been linked with the developmental disorders commonly termed as "channelopathies." 23 In TRPV5, the substitutions were not clustered in the any particular region. Though there are several mutations detected, according to the analysis only very few (14) of them seem to be deleterious.…”
Section: -15mentioning
confidence: 94%
“…30 Similarly, Thr-89-Ile, Lys-197-Arg, and Leu-199-Phe mutations in TRPV4 individually lead to metatropic dysplasia. 23,31 Similarly, a Glu-183-Lys is associated with spondyloepiphyseal dysplasia Maroteux type, 32 and an Arg-232-Cys change with scapuloperoneal spinal muscular atrophy. 33 Accordingly, Arg-269-His and Arg-269-His changes lead to Charcot-Marie-Tooth disease 2C.…”
Section: -15mentioning
confidence: 99%
“…This is also supported by the fact that mutations in either kinesin (Kif1b) or TRPV4 results in same pathophysiology and development of Charcot-Marie-Tooth disease type 2 (CMT2). [33][34][35][36][37] Like kinesins, myosin motors are also involved in the regulation of TRP channels. Mutations in TRP channels as well as in different non-conventional myosin motors develop similar pathophysiological disorders and other syndromes like deafness, blindness, and other sensory defects.…”
Section: Genetic Functional and Physical Interaction And Effect Of Mmentioning
confidence: 99%